Pfizer Vaccine
FDA approves Novavax COVID vaccine with new conditions
The FDA has approved Novavax's COVID-19 vaccine, Nuvaxovid, but with restrictions. It's authorized for individuals 65 and older, and those aged 12-64 with underlying conditions increasing their risk of severe COVID-19. Pediatric studies for children under 12 are still pending. The approval marks a significant step for Novavax, despite earlier delays attributed to the vaccine's composition.
COVID-19: New Zealand to only use Pfizer vaccine
Prime Minister Jacinda Ardern announced the strategy Monday, saying the decision was based on the Pfizer vaccine's effectiveness. She said this would make it easier and fairer for all New Zealanders to have access to the same vaccine.
Omicron variant resistant to antibodies, two vaccine doses: Study
However, the study found that a third dose of the Pfizer vaccine, and mixing Pfizer and AstraZeneca preventives may protect well against the variant.
Dutch give green light for Pfizer shots for children over 5
The children will get shots of the Pfizer vaccine with a lower dose than adults and it is up to their parents whether they are vaccinated. The government stressed that most children infected with the coronavirus develop only mild symptoms, but a small number can become seriously ill.
Covid jab for kids between 6 months to 4 years old approved in Thailand
Children from six months to four years can now get the Covid-19 vaccination. The Ministry of Public Health launched a new campaign to vaccinate young children using the Pfizer vaccine at a significantly lower dosage.
For rich Indians, Dubai is now a travel and Pfizer vaccine vacation destination
The trend started in March, when Dubai allowed resident visa holders to register for vaccines, and has picked up in April, as the Covid-19 scenario in India has turned grimmer. The UAE is vaccinating people aged 40 years or more, that too at no cost.
Pfizer jab less effective, still protects against Indian strain: Study
"Despite slightly diminished efficacy, the Pfizer vaccine probably protects" against the Indian variant, according to laboratory test results, said Olivier Schwartz, the institute's director and co-author of the study that was published on the BioRxiv website ahead of peer review.
Dutch give green light for Pfizer shots for children over 5
The program is set to begin in mid-January, the health ministry said. The children will get shots of the Pfizer vaccine with a lower dose than adults and it is up to their parents whether they are vaccinated.
India may get Pfizer's vaccine against Covid-19 in July
The final agreement between the government and the American drug-maker on indemnity and procurement norms are still pending, though the two parties have arrived at an in-principle consensus, sources said.
Sputnik V protects two times more against Covid than Pfizer's vaccine: Study
Sputnik V in a statement on Thursday said that as per an independent comparative study conducted by the Spallanzani institute in Italy, its Covid-19 vaccine demonstrated strong protection against the Omicron variant of coronavirus, with over two times higher virus neutralising activity compared to the Pfizer's vaccine.
India unlikely to get Pfizer doses via Covax. Here's why
On June 10, the company announced that it had secured 500 million doses of Pfizer/BioNTech’s Covid-19 vaccine at a not-for-profit price for donation to the world's ‘poorest’ countries.
Delay in second shot of Pfizer vaccine boosts immunity in elderly by over 3 times: Study
The finding comes days after the UK government reduced the gap between the two doses of COVID-19 vaccines to eight weeks, while India extended the interval between two doses of the Covishield preventive to 12-16 weeks, up from the previous maximum of eight weeks.
Australia okays Pfizer vaccine, inoculations to begin in February
Residents and workers at aged-care facilities, frontline healthcare workers and quarantine workers are among the groups being prioritised for the first doses.
Pfizer booster shot may start in US by September 20: Anthony Fauci
The rollout for Moderna's booster vaccine could, however, be delayed, CNBC news quoted Anthony Fauci as saying on Sunday. Although both drugmakers have applied to US Food and Drug Administration (FDA) for authorisation of a third dose either six months or eight months after getting the second dose, they haven't been officially approved by the agency.
Pfizer-BioNTech vaccine deliveries could start 'before Christmas'
The vaccine's efficacy was found to be consistent across different ages and ethnicities - a promising sign given the disease has disproportionately hurt the elderly and certain groups including Black people.
Pfizer in vaccine supply talks with India
“For India, Pfizer has offered a not-for-profit price for its vaccine for the government immunization programme. We continue to be in discussions with the government and remain committed to make our vaccine available for deployment in India’s immunization programme," the company spokesperson said in a statement on Thursday.
Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 depending on trials
"Of course we need to see and wait to see how the vaccine's efficacy and safety is demonstrated, hopefully in the coming months," Nanette Cocero, the global head of Pfizer Vaccines, said on a conference call.
US allocates 2 million doses of Pfizer's Covid-19 vaccines for next week
The Food and Drug Administration is expected to approve a second vaccine developed by Moderna later this week. Both vaccines, which require two doses spaced weeks apart, have proved about 95 percent effective in clinical trials, but with side effects such as headaches, fever and fatigue.
EU warns of risks of COVID-19 vaccine race after UK approval of Pfizer shot
The European Medicines Agency which is in charge of approving COVID-19 vaccines for the EU, said its longer procedure to approve vaccines was more appropriate as it was based on more evidence and required more checks than the emergency procedure chosen by Britain.
India to buy Pfizer, Moderna vaccines only at special price
The govt could essentially function as a canalising agency to facilitate supply of these vaccines in the country. Pfizer had not participated in the tenders floated by state governments, saying it will only deal with the Centre for its vaccine, which is based on the novel mRNA technology.
US FDA nod may help speed up Pfizer vaccine rollout in India
“India will have to give approval if it has to secure free doses of Pfizer vaccine from the Covax facility,” an official said. “Without giving an approval, India will not be able to receive those free doses.”
Booster shot of Pfizer Covid vaccine can cut mortality from Delta variant by 90%: Study
A total of 843,208 participants met the eligibility criteria, of whom 758,118 (90 per cent) received the booster during the 54-day study period, according to the researchers, including those from Clalit Health Services and Ben-Gurion University of the Negev, Israel.
First shipments of Pfizer vaccine leave Michigan manufacturing facility
The first trucks carrying the vaccine for widespread use in the US pulled out of a Pfitzer manufacturing plant in Michigan on Sunday, en route to 636 predetermined locations, amid a botched government response that has made the US the worst-hit country in the world.
Covid infection risk increases gradually after second Pfizer jab: Study
Israel was one of the first countries to roll out a large scale COVID-19 vaccination campaign in December 2020, but has seen a resurgence of infections since June 2021.
India may not need Pfizer’s vaccine, says Harsh Vardhan
Health minister says does not make sense to consider it as US hasn’t given licence to Pfizer
Pfizer, AstraZeneca vaccine antibody levels may decline after 2-3 months: Lancet study
The researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping at this rate, there are concerns that the protective effects of the vaccines may also begin to wear off, particularly against new variants.
US President Joe Biden gets COVID-19 booster shot after authorisation
The U.S. Centers for Disease Control and Prevention (CDC) last week backed an additional dose of the Pfizer Inc /BioNTech vaccine for Americans aged 65 and older, adults with underlying medical conditions and adults in high-risk working and institutional settings.
Pfizer: Vaccine effective up to 6 months later
The company said the vaccine was 91 per cent effective against symptomatic disease and was even more protective in preventing severe disease. Of 927 confirmed COVID-19 cases detected through March 13, 77 were among people who received the vaccine and 850 were among people who got dummy shots.
EU's marathon COVID vaccination drive off to uneven start
The vaccination drive kicked off at the weekend, with health workers and residents of care homes across the bloc among the first to get the Pfizer and BioNTech shots, which must be kept at ultra-cold temperatures.
How much COVID-19 vaccine will be shipped in US
The first wave of shipments is going to health care workers and nursing home residents. Officials say vaccines should be available to everyone by the middle of next year.
Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95 per cent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Australia halts AstraZeneca vaccine for most people under 50
PM Scott Morrison said he'd received a series of recommendations from an advisory group on Thursday night, and that chief among them was that the Pfizer vaccine should now be adopted as the preferred vaccine for people aged under 50.
Covid booster dose effective in reducing severe disease outcomes: Lancet study
It is the first to estimate the effectiveness of a third dose of Pfizer-BioNTech mRNA COVID-19 vaccine against severe outcomes with adjustment for various possible confounders, including comorbidities and behavioural factors. A recent clinical trial conducted by BioNTech included a smaller sample size and did not estimate the third-dose's effects for more severe outcomes.
World watches as first-mover Britain probes adverse reactions to Pfizer vaccine
Officials from around the world are keen for British authorities to give them as much information as possible about the two reported cases of anaphylaxis among thousands of people inoculated since mass-vaccination began on Tuesday.
Is the COVID-19 vaccine safe for children?
Is the COVID-19 vaccine safe for children? Very rarely, teens and young adults given the Pfizer vaccine or a similar one made by Moderna experience a serious side effect, heart inflammation, or what doctors call myocarditis. It's mostly in young men or teen boys, and usually after the second dose.
Bahrain approves Chinese COVID-19 vaccine for use
The Sinopharm vaccine has been approved for emergency use in a few countries and the company is still conducting late-stage clinical trials in 10 countries. Morocco is gearing up for an ambitious COVID-19 vaccination program, aiming to vaccinate 80% of its adults in an operation starting this month that's relying initially on the Sinopharm vaccine.
Single dose of Pfizer and Astrazeneca Covid vaccines highly effective: Studies
Israeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on more than 9,000 medical staff at Sheba hospital near Tel Aviv.
Britain's Queen Elizabeth may go public after having COVID vaccine, Times reports
The 94-year-old monarch and her 99-year-old spouse are likely to be among the first to be offered a jab, with the government prioritising elderly people as it begins the rollout of the Pfizer vaccine that was approved on Dec. 2.
US close on deal with Pfizer for millions more vaccine doses
A person with knowledge of the negotiations told The Associated Press on Tuesday that the deal is under discussion and could be finalized shortly.
US to donate half a billion Pfizer vaccines to low and lower-middle-income countries
This is the largest-ever purchase and donation of vaccines by a single country and a commitment by the American people to help protect people around the world from COVID-19, the White House said ahead of the announcement by Biden at the G-7 Summit in the UK.
Tata, Godrej making Moderna, Pfizer vaccine storage units
Blue Star, another major player in cold chain manufacturing, is ramping up production of medical refrigeration units for Covaxin and Covishield, which will soon be supplied in larger quantities, as well as those units that can store the Sputnik V and Johnson & Johnson vaccines.
Pfizer vaccine results leave questions about safety, longevity
Questions about production, distribution and, most importantly, the performance and capability of the shot itself still need to be answered, even if the numbers look highly promising, according to vaccine specialists.
Five or six doses? Controversy over Pfizer vaccine vials
Pfizer has revised higher its production target for this year from 1.3 billion doses to 2 billion. While part of that reflects plans to further increase output, it also reflects the effect of the label change on vials.
Dubai aims to inoculate 70% of population with Pfizer vaccine in 2021
The financial hub of the United Arab Emirates began the first phase of the vaccination campaign last week, targeting "priority groups", including those 60 and older, people with chronic medical conditions, those with disabilities and frontline workers.
WHO reviewing Pfizer vaccine for possible emergency listing: Statement
Referring to Britain's regulator, the Medicines and Healthcare products Regulatory Agency, it said in a statement to Reuters: "WHO is also in discussions with MHRA on the possibility of accessing some of the information from their assessment, which could expedite WHO’s emergency listing".
UK warns people with serious allergies to avoid Pfizer vaccine
Britain began mass vaccinating its population on Tuesday in a global drive that poses one of the biggest logistical challenges in peacetime history, starting with the elderly and frontline workers.
Pfizer vaccine stops Covid's spread, finds Israeli study
The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.
German COVID-19 fight hit by delay to Pfizer vaccine
Pfizer started delivering shots in the European Union at the end of December but announced on Friday there would be a temporary impact on shipments in late January to early February caused by changes to manufacturing processes to boost output.
Covid vaccines: Indemnity Issue, here's everything to know about it
Indian contract law defines indemnity as: “A contract by which one party promises to save the other from loss caused to him by the contract of the promisor himself, or by the conduct of any other person, is called a contract of indemnity.”
Pfizer's COVID-19 vaccine just received full FDA approval. Here's what it means
In early August, a Wall Street Journal report stated that India was in talks to buy 50 million doses of Pfizer and German partner BioNTech COVID-19 vaccine, citing people familiar with the matter.
Anthony Fauci says Pfizer vaccine's trial success may boost acceptance
Pfizer’s vaccine, developed in collaboration with Germany’s BioNTech SE, has “an extraordinarily high degree of efficacy — more than 90%, close to 95%,” Fauci said in an interview.
Will children be able to get Covid vaccines? Experts say more data is needed to ascertain safety
Depending on the results, younger children may be enrolled for study as well.
Covid-19 vaccine: When will children be able to get the shots?
The Moderna vaccine is currently cleared for people 18 and older.
Pfizer vaccine appears effective against coronavirus variant found in Britain: Study
The encouraging results from an analysis of blood of participants in trials are based on more extensive analysis than those released by the U.S. drugmaker last week.
Overseas indemnity new hurdle in India rollout of Pfizer Covid vaccine
India is reluctant to provide such overseas indemnity but is in talks for an early resolution to facilitate the supply of the Pfizer-BioNTech Covid-19 vaccine in the private sector, an official said.
'Real-world' UK data shows 70% decline in COVID infections after first Pfizer shot
Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose, and that hospitalisation and death from COVID-19 will be reduced by more 75% in elderly people who have had a first dose.
India in talks to find 'middle ground' with Pfizer, others for vaccine imports-Government official
Any final decision on vaccine imports has to be compatible with Indian laws and the government was hopeful that these vaccines would be available in the country before the end of this year, Paul said.
Ivanka Trump gets her first Covid shot, urges others to get vaccinated
She received the Pfizer vaccine in Florida, where individuals age 16 and above are eligible to be vaccinated.
Britain yet to decide on Pfizer offer to vaccinate Olympians
Pfizer, which developed a vaccine with BioNTech, said earlier this month said that it would donate doses to inoculate athletes and officials preparing for the Tokyo games with the rescheduled Olympics due to open on July 23.
Sanofi says its coronavirus vaccine won’t require supercooling
The companies said they expect to supply up to 50 million vaccine doses globally in 2020, and up to 1.3 billion doses in 2021.
Oil extends rally amid coronavirus vaccine rollouts
Brent was up 30 cents or 0.6% at $50.55 a barrel by 0752 GMT, after gaining nearly 3% on Thursday. U.S. oil was up 31 cents, or 0.7%, at $47.09 a barrel, having also risen almost 3% in the previous session.
Britain working with Pfizer, AstraZeneca to increase vaccine supplies
"The rate limiting step is the supply of vaccine, and we're working with the companies, both Pfizer and of course AstraZeneca, to increase the supply," Hancock told broadcasters.
Pfizer vaccine can neutralise coronavirus variants first reported in UK, SA: Study
According to the scientists, including those from the University of Texas in the US, these variants have a substitution of the amino acid building blocks that make up the viral spike protein -- the part of the virus which enables it to enter human cells.
Bahrain announces free Covid vaccine for public, Saudi Arabia approves Pfizer jab
Bahrain plans to inoculate everyone 18 years and older in the kingdom at 27 different medical facilities, hoping to be able to vaccinate 10,000 people a day. Bahrain, an island in the Persian Gulf home to the U.S. Navy's 5th Fleet, has a population of around 1.5 million people.
UK vaccine approval 'historic moment' in Covid-19 battle: Pfizer CEO
"Today's Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19," said Pfizer CEO Albert Bourla.
Government needs to define COVID-19 vaccine distribution strategy: Rahul Gandhi
Rahul Gandhi attached a media report with his tweet, saying that no cold chain logistic company in India has the capability to transport the Pfizer vaccine for COVID-19 to India which required a temperature of minus 70 degrees.
EU drug regulator evaluating Pfizer vaccine for youngsters
In a statement Friday, the two pharmaceuticals said their request is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective. The children will continue to be monitored for longer-term protection and safety for another two years.
How does the Johnson & Johnson vaccine compare to other coronavirus vaccines? 4 questions answered
Maureen Ferran, a virologist at the Rochester Institute of Technology, explains how this third authorized vaccine works and explores the differences between it and the Moderna and Pfizer-BioNTech vaccines that are already in use.
WHO recommends reduced dose Pfizer COVID vaccine for under 12s
The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday to evaluate the vaccine. It is currently recommended for use in people aged 12 years and above. The recommended dosage for the younger population is 10 micrograms instead of 30 micrograms offered to those 12 years and older.
WHO says deal with Pfizer to allow poor countries to start vaccinating in February
The COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income countries, but has yet to begin vaccinations. Pfizer's vaccine is so far the only one that has WHO emergency approval.
Covid: Why T cell vaccines could be the key to long-term immunity
Evidence directly on COVID and T cells is still being gathered. However, it's gradually becoming clearer that T cells do seem to play a big role in COVID.
One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study
The researchers from King's College London in the UK also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days.
Breakthrough infections generate strong immunity to COVID-19 variants, according to study
The study found that antibodies measured in blood samples of breakthrough cases were both more abundant and much more effective -- as much as 1,000 per cent -- than antibodies generated two weeks following the second dose of the Pfizer vaccine. The results suggest each exposure following vaccination actually serves to strengthen immune response to subsequent exposures even to new variants of the virus.
Gurgaon company’s technology to cart vaccines at desired temperature
The application, which is based on what is called ‘phase-change’ technology, uses safe chemicals to provide solutions for the pharmaceutical industry, logistics and can even be used for cooling and heating buildings.
India close to giving indemnity to foreign vaccine makers like Pfizer, say sources
Pfizer has not sold to any country without obtaining indemnity against legal action over any adverse effects of their product. India has not granted indemnity to any COVID-19 vaccine maker, but the sources, who requested anonymity, said the government was having a change of heart.
Hong Kong halts use of Pfizer vaccine, cites defective lids
BioNTech and Fosun Pharma have not found any reason to believe the product is unsafe, according to the statement. However, vaccinations will be halted as a preventive and safety measure.
Why the CDC recommends wearing masks indoors, even if you've been fully vaccinated
The reason public health officials are calling for more mask-wearing is that there is clear and mounting evidence that - though rare - breakthrough COVID-19 infections can occur in people who are fully vaccinated. This is particularly true with emerging variants of concern. The good news is that COVID-19 infection, if it does happen, is much less likely to lead to serious illness or death in vaccinated people.
US medical experts recommend emergency authorisation of Pfizer COVID vaccine
An emergency use authorisation (EUA) is short of a full approval. Pfizer would have to file a separate application for full FDA approval for its vaccine. Thursday's vote does not mean the vaccine will be authorised immediately, US media reported.
Pfizer vaccinations for 16 to 39-year-olds is welcome news. But AstraZeneca remains a good option
Importantly, given what we know about the high rates of COVID infections in younger people, and the significant role they're playing in transmission, this is good news. Boosting vaccination rates in this group will be a crucial step towards controlling the virus.
Fourth vaccine dose protects elderly from Covid but protection wanes quickly: Study
The study, published in New England Journal of Medicine on Tuesday, used the Israeli Ministry of Health database to extract data on 1,252,331 persons 60 years of age or older and eligible for the fourth dose during a period in which the Omicron variant was predominant.
Pfizer booster shot 95.6 pc effective against Covid-19
In a tweet BioNTech said, "95.6% relative vaccine efficacy against #Covid19 after a booster shot with our #mRNA vaccine, during a period when Delta was the prevalent strain. These are the first efficacy results from any randomized, controlled vaccine booster trial."
Vaccination drive: Godrej expects 40% uptick in medical refrigerator revenues in FY21
he share of medical refrigeration equipment used for vaccine storage in the overall revenue pie of Godrej Appliances is also likely to go up to 8 per cent on the back of the high revenue growth, the official said.
Mexico says Pfizer vaccine doses could arrive in 5-8 days
"The request is being made today, and according to our contract, we could have it here in a period of something like five to eight days," Delgado told broadcaster Televisa.
MSF and Pfizer battle over patent application for life-saving pneumonia vaccine
MSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious and predictable.
Deep-freeze hurdle makes Pfizer’s vaccine one for the rich
Countries will need to build from scratch the deep-freeze production, storage and transportation networks needed for the vaccine to survive. The massive investment and coordination required all but ensures that only rich nations are guaranteed access -- and even then perhaps only their urban populations.
New Zealand plans to start reopening borders early next year
Officials also said they would delay second shots of the Pfizer vaccine in order to speed up first shots to protect more people as the threat of the delta variant grows. New Zealand's success in erasing the coronavirus has allowed life to return almost to normal.
Pfizer vaccine likely by July; govt weighs indemnity request
“We are engaged in talks with Pfizer because they have indicated availability of a certain volume of vaccines in the coming months, possibly beginning in July,” said VK Paul, member, health, Niti Aayog, at the daily health ministry briefing on Thursday.
EC rebuked for not disclosing texts over Pfizer vaccine deal
In an interview in April, von der Leyen revealed she had exchanged texts with Bourla for a month when they were negotiating a vaccine contract. But in response to a public access request by a journalist, the Commission later said no record had been kept of such messages.
Pfizer vaccine moves closer to getting the OK in the United States
The encouraging developments come as the coronavirus continues surging across much of the world. The scourge has claimed more than 1.5 million lives, including over 285,000 in the US, the highest toll of any country.
US regulators post positive review of Pfizer vaccine data
The Food and Drug Administration posted its analysis online even as across the Atlantic, Britain on Tuesday began vaccinating its oldest citizens with the Pfizer-BioNTech shots.
US FDA says working to authorize Pfizer vaccine fast
A panel of outside advisers to the FDA on Thursday voted overwhelmingly to endorse emergency use of the vaccine, paving the way for the agency to authorize the shot for a country that has lost more than 285,000 lives to COVID-19.
Malaysia secures Pfizer vaccine in a first for Southeast Asia
Malaysia has agreed to buy 12.8 million doses of Pfizer’s Covid-19 vaccine, becoming the first country in Southeast Asia to announce a deal with the US drugmaker after some expressed reservations over the need for ultra-cold storage.
Dubai offers Pfizer vaccine to 12-15 year olds
The Reuters COVID-19 tracker shows that the UAE has among the world's highest immunisation rates, with about two thirds of its population having taken two doses of the Pfizer-BioNtTech, Sinopharm, AstraZeneca or Sputnik V vaccines.
Received bid for Pfizer vaccine, says BMC; company denies
The Municipal Corporation of Greater Mumbai said on Tuesday that it has received eight bids for the global tender floated by it for the procurement of 10 million Covid-19 vaccine doses. Pfizer, however, told it has not authorised any company to bid on its behalf.
